Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture. (Q48102254)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

title

Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

main subject

neoplastic stem cells

1 reference

based on heuristic

inferred from title

trastuzumab

1 reference

based on heuristic

inferred from title

author

Damian E Berardi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

Gabriel L Fiszman

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

author name string

Cristina E Rodríguez

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

Marianela Abrigo

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

Laura B Todaro

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

Elisa D Bal de Kier Joffé

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

publication date

25 September 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

published in

Journal of Cellular Biochemistry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

volume

119

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

page(s)

1381-1391

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

cites work

Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

The tumor microenvironment is a dominant force in multidrug resistance.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Mammary stem cells, self-renewal pathways, and carcinogenesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Mechanisms of chemoresistance in cancer stem cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

HER2 and breast cancer stem cells: more than meets the eye.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Tumor microenvironment-mediated chemoresistance in breast cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

The hypoxic microenvironment: A determinant of cancer stem cell evolution

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCB.26298

retrieved

21 January 2018

Identifiers

DOI

10.1002/JCB.26298

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

PubMed publication ID

28722778

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28722778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 March 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48102254&oldid=1561177924"